• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-08-14

  FITC-Concanavalin A (ConA) Conjugate provides a direct fluorescent approach for detecting accessible α-D-glucose and α-D-mannose residues on cell surfaces, tissue sections, and other glycan-containing samples. It is intended for carbohydrate-binding workflows such as immunofluorescence staining and flow cytometry, not for non-glycan targets or assays performed outside the specified storage and handling conditions.

• SIRT1/2 Inhibitor IV Astrocyte Assay Guide

  2026-08-14

  Use SIRT1/2 Inhibitor IV (cambinol) to interrogate how SIRT1/2 activity connects metabolic stress with protein modification, STAT3 trafficking, and astrocyte state. This guide translates the Ran lactylation findings into controlled cell-based workflows while separating established product data from practical assay recommendations.

• CFTRinh-172 Workflows for Epithelial Research

  2026-08-13

  CFTRinh-172 provides a rapid, selective way to separate CFTR chloride transport from upstream cAMP signaling in airway, intestinal, and other epithelial models. This guide translates that pharmacology into assay-ready workflows for cystic fibrosis research, trafficking studies, and secretory diarrhea models, with practical controls and troubleshooting.

• Pitavastatin (NK-104): In Vitro Protocol Guide

  2026-08-13

  Pitavastatin (NK-104) provides a defined HMG-CoA reductase inhibition tool for cellular and biochemical studies of cholesterol synthesis. This guide covers preparation, controls, and quality checks for in vitro work; the product should not be treated as validated for clinical, therapeutic, or unvalidated animal use.

• Olive Biophenols and Alzheimer’s Pathology

  2026-08-12

  The reference study combined cell-free amyloid assays, SH-SY5Y neuroblastoma experiments, and an APPswe/PS1dE9 mouse model to examine whether olive biophenols could reduce amyloid-β42 aggregation and toxicity. Oleuropein-containing olive leaf extract reduced plaque deposition in mouse cortex and hippocampus, while oleuropein, verbascoside, and rutin showed prominent anti-amyloidogenic activity in vitro.

• n-Dodecyl-β-D-maltoside for Enzyme Assays

  2026-08-12

  Discover how n-Dodecyl-β-D-maltoside, or DDM, can be treated as an active assay-design variable rather than a passive extraction reagent. This guide connects micelle chemistry with functional testing of difficult multi-pass membrane enzymes such as WecA.

• Trilaurin in Oral Nanomedicine and Biocatalysis

  2026-08-11

  Trilaurin, also known as Glycerol Tridodecanoate, is more than a hydrophobic lipid: its defined C12 architecture supports enzyme reactions and advanced oral nanomedicine. This article explains how its material properties influence formulation design, assay controls, and translational interpretation.

• Rimonabant (SR141716) for CB1 Research

  2026-08-11

  Rimonabant (SR141716) gives researchers a selective way to interrogate CB1 signaling in withdrawal, appetite, and inflammation models. This workflow-focused guide connects receptor pharmacology with sex-aware behavioral design, solvent handling, and troubleshooting for more reproducible experiments.

• Trilaurin Protects Desmopressin in Lipid Particles

  2026-08-10

  The reference study developed an in vitro model that couples triglyceride lipolysis with proteolytic degradation to examine how solid lipid microparticles affect desmopressin release and stability. Its key finding was that Trilaurin, or Glycerol Tridodecanoate, can alter both release behavior and protease exposure, supporting its evaluation as a lipid excipient for oral peptide and protein delivery.

• Angiotensin II Workflows for Vascular Research

  2026-08-09

  Build reproducible vascular stress, hypertrophy, and remodeling assays with Angiotensin II, from short cell-based signaling experiments to sustained abdominal aortic aneurysm models. This guide connects controlled receptor stimulation with senescence-biomarker validation, while emphasizing dosing, peptide handling, and troubleshooting.

• Acetylcholine Chloride in Gut-Brain Translation

  2026-08-08

  A translational framework for using Acetylcholine Chloride to interrogate gut-vagus-brain cholinergic signaling, informed by recent evidence that Bacteroides fragilis suppresses seizures through a colonic ChAT-positive circuit.

• Septin4, VHL, and HIF-1α in Hypoxic Cardiac Injury

  2026-08-07

  The reference study identifies Septin4 as a previously unrecognized regulator of hypoxia-induced cardiomyocyte injury. Its data support a model in which Septin4 associates with HIF-1α and promotes VHL-dependent ubiquitination and proteasomal degradation, linking a proapoptotic protein to impaired hypoxic adaptation.

• TH287 MTH1 Inhibitor: Mechanistic Insights & Translational I

  2026-08-07

  Explore the unique mechanism and translational relevance of the TH287 MTH1 inhibitor in cancer research. This article delivers an advanced analysis of its role in radiosensitization, oxidative DNA damage, and selective cytotoxicity, offering guidance for assay design and future applications.

• SCP4 Controls Mitotic Fidelity by Dephosphorylating Histone

  2026-08-06

  The reference study identifies SCP4 as a chromatin-associated phosphatase that specifically dephosphorylates histone H3 at threonine 3 during mitosis. This finding clarifies a previously unresolved mechanism ensuring chromosome stability and highlights the importance of balanced post-translational histone modifications for genomic integrity.

• Pharmacokinetic Variability of Corydalis saxicola Alkaloids

  2026-08-06

  This study rigorously characterizes how pathological states such as metabolic dysfunction-associated steatohepatitis (MASH) alter the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids in mouse models. The findings highlight the mechanistic impact of disease-driven changes in drug metabolism and transporter expression, providing a framework for rationalizing dosing in MASLD/MASH research.

16588 records 1/1106 page Next 12345 下5页 Last page